Navigation Links
Nitric Oxide Supplements Website Nitro Solution Posts New Article about the Benefits of Amlodipine
Date:11/11/2013

LOS ANGELES, Nov. 11, 2013 /PRNewswire-iReach/ -- Nitro Solution, a website that offers high quality and all natural nitric oxide supplements, has just posted a new article to its website that addresses a new study that looked at the unexpected benefits of a drug called Amlodipine.

(Photo: http://photos.prnewswire.com/prnh/20131111/MN13653)

As the article explains, the popular blood pressure drug, which is sold under the name of Norvasc, had previously been found to help reduce the rates of both heart attack and stroke—much more than researchers would expect the medication to do on its own.

In the new study, which was published in the "American Journal of Hypertension" in late October, researchers looked at exactly why Amlodipine is so impressive for stroke and heart attack prevention. As the scientists discovered, the drug increases the body's nitric oxide production by the endothelium, which is the thin lining of the artery wall. This increase in nitric oxide then causes the artery to dilate which in turn lowers the blood pressure. In addition, the nitric oxide has a natural anti-inflammatory effect on the artery wall that prevents the damage that causes atherosclerotic plaque. This plaque causes high blood pressure, and also leads to heart attack and stroke.

Although the study's results indicate a great benefit for those who take Amlodipine, the article notes that the drug does come with its share of negative side effects, including headaches, fatigue, nausea, and swelling of the hands and feet.

Fortunately, those who are looking for natural ways to lower blood pressure and heart disease prevention can find safe and effective supplements that will also boost
'/>"/>

SOURCE Nitro Solution
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Light-induced delivery of nitric oxide eradicates drug-resistant bacteria
2. Remarkable enzyme points the way to reducing nitric acid use in industry
3. Fertilizer use responsible for increase in nitrous oxide in atmosphere
4. Growing nitrous oxide levels explained
5. Increasing levels of carbon dioxide in Arctic coastal seas
6. UC Berkeley chemists installing first carbon dioxide sensor network in Oakland
7. Geologists testing aquifer rocks as containers to permanently trap carbon dioxide
8. Rising carbon dioxide in atmosphere also speeds carbon loss from forest soils, IU-led research finds
9. Study shows economic feasibility for capturing carbon dioxide directly from the air
10. Controlling gene expression with hydrogen peroxide switches
11. Anti-angina drug shows protective effects from carbon monoxide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... 9, 2015  Unchained Labs just can,t get ... of Avid Nano. Avid Nano designs, develops and ... Also today, Unchained Labs UNcaged ... to use protein sizing system. The pUNk is ... hydrodynamic size, size distribution, aggregation population and molecular ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... are leading the largest ever international research project into ... The research will aim to provide new insights into ... kills up to 40,000 women and almost one million ... study, DNA collected from thousands of pregnant women, including ...
... about to be published in EPJ E, French physicists from ... of a thin layer of cells in contact with an ... elastic films. Understanding the mechanism by which a thin layer ... structural integrity, bears great significance because the human tissue, or ...
... TAMPA, Fla. (May 16, 2012) Chlorothalonil, ... on food crops and golf courses, was lethal to ... study, University of South Florida researchers said Wednesday. ... study published in the journal Ecology Letters , ...
Cached Biology News:Nottingham researchers lead world's largest study into pre-eclampsia 2USF study: Common fungicide wreaks havoc on freshwater ecosystems 2
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... across the globe, ISN improves the efficiency and effectiveness of contractor management systems. ISN,s ... reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Headquartered in Dallas, TX , ISN has additional offices in Calgary ...
(Date:7/30/2015)... -- HIGHLIGHTS:Q2 2015 Results (all changes are ... sales were $697 million compared to $701 million in ... 8%, and changes in foreign currency exchange rates decreased ... , By business unit, organic sales growth was ... SAFC Commercial. , Reported diluted EPS was $0.98 ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... Cup may be two years away, but soccer aficionados ... for global competition when the National Institute of Standards ... second-ever international nanosoccer contest next summer. , Nanosoccerthe Lilliputian ... challenge one another on fields no bigger than a ...
... November 14, 2008 at 9:00 a.m. Eastern ... ... Inc. (Nasdaq: ALSE ) today reports operational and,financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO ), "We are encouraged by the ...
... Spherix Incorporated,(Nasdaq: SPEX ) reported a net ... 2008 of $1.7 million ($0.12 per share) and $4.8 ... related to the commercialization of Naturlose as a treatment ... nine month period ended,September 30, 2008, compared to approximately ...
Cached Biology Technology:Let the games begin! Nanosoccer at 2009 RoboCup in Austria 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 3Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 4Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 5Spherix Reports 3rd Quarter Earnings 2